Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 11/20 | 0.55 |
| ▸ | NPY1R | P25929 | 6/20 | 0.55 |
| ▸ | NPY2R | P49146 | 4/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.55 |
| ▸ | TFPI | P10646 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29993329 | 1.00 | NPY4R (0.55) | NPY4RNPY1RNPY2RNPY5RTFPI | |
| SCHEMBL7456624 | 0.96 | TFPI (0.56) | NPY4RNPY1RNPY2RNPY5RTFPI | |
| SCHEMBL7456632 | 0.96 | TFPI (0.56) | NPY4RNPY1RNPY2RNPY5RTFPI | |
| SCHEMBL29379362 | 0.92 | NPY4R (0.60) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL32664689 | 0.91 | NPY4R (0.68) | NPY4RNPY1RNPY2RNPY5RTFPI | |
| SCHEMBL30798743 | 0.91 | NPY4R (0.60) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL9551261 | 0.91 | BACE1 (0.55) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29590426 | 0.90 | NPY4R (0.52) | NPY4RNPY1RNPY2RNPY5RTFPI | |
| SCHEMBL30384921 | 0.89 | BACE1 (0.56) | NPY4RNPY1RNPY2RNPY5RTFPI | |
| SCHEMBL30933937 | 0.89 | NPY4R (0.52) | NPY4RNPY1RNPY2RNPY5RTFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12435143-B2 | Caninized antibodies against canine CTLA-4 | INTERVET INC. (US) | 2025-10-07 | — | — | US | disclosed |
| US-20220251208-A1 | Caninized Antibodies Against Canine CTLA-4 | INTERVET INC. (US) | 2022-08-11 | — | — | US | disclosed |